These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17698496)

  • 1. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
    Lockhart A; Lamb JR; Osredkar T; Sue LI; Joyce JN; Ye L; Libri V; Leppert D; Beach TG
    Brain; 2007 Oct; 130(Pt 10):2607-15. PubMed ID: 17698496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
    Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
    J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease.
    Rosen RF; Ciliax BJ; Wingo TS; Gearing M; Dooyema J; Lah JJ; Ghiso JA; LeVine H; Walker LC
    Acta Neuropathol; 2010 Feb; 119(2):221-33. PubMed ID: 19690877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression.
    Beckett TL; Webb RL; Niedowicz DM; Holler CJ; Matveev S; Baig I; LeVine H; Keller JN; Murphy MP
    J Alzheimers Dis; 2012; 32(1):127-38. PubMed ID: 22766739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
    Kadir A; Marutle A; Gonzalez D; Schöll M; Almkvist O; Mousavi M; Mustafiz T; Darreh-Shori T; Nennesmo I; Nordberg A
    Brain; 2011 Jan; 134(Pt 1):301-17. PubMed ID: 21149866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
    Driscoll I; Troncoso JC; Rudow G; Sojkova J; Pletnikova O; Zhou Y; Kraut MA; Ferrucci L; Mathis CA; Klunk WE; O'Brien RJ; Davatzikos C; Wong DF; Resnick SM
    Acta Neuropathol; 2012 Dec; 124(6):823-31. PubMed ID: 22864813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease.
    Higuchi M
    Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.
    Johnson KA; Gregas M; Becker JA; Kinnecom C; Salat DH; Moran EK; Smith EE; Rosand J; Rentz DM; Klunk WE; Mathis CA; Price JC; Dekosky ST; Fischman AJ; Greenberg SM
    Ann Neurol; 2007 Sep; 62(3):229-34. PubMed ID: 17683091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load.
    Alkalay A; Rabinovici GD; Zimmerman G; Agarwal N; Kaufer D; Miller BL; Jagust WJ; Soreq H
    Curr Alzheimer Res; 2013 Jan; 10(1):48-56. PubMed ID: 23157337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
    Aalto S; Scheinin NM; Kemppainen NM; Någren K; Kailajärvi M; Leinonen M; Scheinin M; Rinne JO
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1651-60. PubMed ID: 19495749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MR-less PiB SUVR quantification methods.
    Bourgeat P; Villemagne VL; Dore V; Brown B; Macaulay SL; Martins R; Masters CL; Ames D; Ellis K; Rowe CC; Salvado O; Fripp J;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S159-66. PubMed ID: 25257985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.
    Verhoeff NP; Wilson AA; Takeshita S; Trop L; Hussey D; Singh K; Kung HF; Kung MP; Houle S
    Am J Geriatr Psychiatry; 2004; 12(6):584-95. PubMed ID: 15545326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Structural Modifications on the Competition of Chalcones for the PIB Amyloid Imaging Ligand-Binding Site in Alzheimer's Disease Brain and Synthetic Aβ Fibrils.
    Fosso MY; McCarty K; Head E; Garneau-Tsodikova S; LeVine H
    ACS Chem Neurosci; 2016 Feb; 7(2):171-6. PubMed ID: 26682772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study.
    Degerman Gunnarsson M; Lindau M; Wall A; Blennow K; Darreh-Shori T; Basu S; Nordberg A; Larsson A; Lannfelt L; Basun H; Kilander L
    Dement Geriatr Cogn Disord; 2010; 29(3):204-12. PubMed ID: 20332638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
    Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
    Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils.
    Yamin G; Teplow DB
    J Neurochem; 2017 Jan; 140(2):210-215. PubMed ID: 27943341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.